Article By:
Bio Deep Dives
Monday, August 14, 2023 11:24 AM EDT
BriaCell has recently announced agreement with the FDA for their pivotal, registration trial in advanced metastatic breast cancer.
In this article: BCTX
BriaCell: An Emerging Immuno-Oncology Company
Some good analysis on $BCTX, thanks.
BriaCell Therapeutics' Mission: Destroy Breast Cancer
I'm in. Bullish on $BCTX
BriaCell Therapeutics' Mission: Destroy Breast Cancer
$BCTX is an exciting company, with a great pipeline and a ton of potential.
BriaCell Therapeutics' Mission: Destroy Breast Cancer
$BCTX sound very promising. Good news came out today.